Predictors of red cell folate level in women attempting pregnancy

JAMA

Volumn 277, Issue 7, 1997, Pages 548-552

  Brown, Judith E ^a   Jacobs, David R ^a   Hartman, Terryl J ^b   Barosso, Geralyn M ^a   Stang, Jamie S ^a   Gross, Myron D ^a   Zeuske, Melanie A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FOLIC ACID; ZINC;

ADULT; ARTICLE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL CARE; NEURAL TUBE DEFECT; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; VITAMIN INTAKE; ZINC BLOOD LEVEL;

EID: 0031057030     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.7.548     Document Type: Article

References (46)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338: 131-137.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835.
3. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ. 1981;282:1509-1511.
4. Smithells RW, Sheppard S, Schorah CJ, et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child. 1981;56:911-918.
5. Smithells RW. Neural tube defects: prevention by vitamin supplements. Pediatrics. 1982;69:498-499.
6. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust. 1989;150:613-619.
7. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219-226.
8. Shaw GM, Velie EM, Schaffer DM. Risk of neural tube defect-affected pregnancies among obese women. JAMA. 1996;275:1093-1096.
9. Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA. 1996;275:1089-1092.
10. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345:149-151.
11. Steegers-Theunissen RP. Folate metabolism and neural tube defects: a review. Eur J Obstet Gynecol Reprod Biol. 1995;61:39-48.
12. 12 are independent risk factors for neural tube defects. Q J Med. 1993;86:703-708.
13. Butterworth CE Jr. Folate status, women's health, pregnancy outcome, and cancer. J Am Coll Nutr. 1993;12:438-441.
14. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep. 1992;41(RR-14):1-7.
15. Smithells RW. Diet and congenital malformation. In: Campbell DM, Gillmer MDG, eds. Nutrition in Pregnancy: Proceedings of the Tenth Study Group of the Royal College of Obstetricians and Gynaecologists, September 1982. London, England: Royal College of Obstetricians and Gynaecologists; 1983:155-163.
16. Hambidge M, Hackshaw A, Wald N. Neural tube defects and serum zinc, Br J Obstet Gynaecol. 1993;100:746-749.
17. Werter MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993;269:1257-1261.
18. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51:944-950.
19. Mulinare J, Cordero JF, Erickson D, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;260: 3141-3145.
20. Milunsky A, Jick H, Jick SS, et al. Multivitamin/ folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262:2847-2852.
21. Laurence KM, James N, Miller M, Campbell H. Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. BMJ. 1980;281:1592-1594.
22. Yates JRW, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, Clark BJ. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet. 1987;31:279-287.
23. Bailey LB. Evaluation of a new Recommended Dietary Allowance for folate. J Am Diet Assoc. 1992;92:463-471.
24. Bunduki V, Dommergues M, Zittoun J, Marquet J, Muller F, Dumez Y. Maternal-fetal folate status and neural tube defects: a case control study. Biol Neonate. 1995;67:154-159.
25. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. JAMA. 1995;274:1698-1702.
26. 12. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease. 8th ed, Philadelphia, Pa: Lea & Febiger; 1994:402-422.
27. Brown JE, Jacobs DR Jr, Barosso GM, et al. Recruitment, retention and characteristics of women in a prospective study of preconceptual risks to reproductive outcomes: experience of the Diana Project. Paediatr Perinat Epidemiol. In press.
28. Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML. Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc. 1987; 87:43-47.
29. Brown JE, Buzzard IM, Jacobs DR Jr, et al. A food frequency questionnaire can detect pregnancy-related changes in diet. J Am Diet Assoc. 1996;96: 262-266.
30. Krumdieck CL, Fukushima K, Fukushima T, Shiota T, Butterworth CE Jr. A long-term study of the excretion of folate and pterins in a human subject after ingestion of 14C folic acid, with observations on the effect of diphenylhydantoin administration. Am J Clin Nutr. 1978;31:88-93.
31. Dansky LV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology. 1992;42:32-42.
32. O'Keefe CA, Bailey LB, Thomas EA, et al. Controlled dietary folate affects folate status in nonpregnant women. J Nutr. 1995;125:2717-2725.
33. Colman N. Addition of folic acid to staple foods as a selective nutrition intervention strategy. Nutr Rev. 1982;40:225-233.
34. Mukherjee MD, Sandstead HH, Ratnaparkhi MV, Johnson LK, Milne DB, Stelling HP. Maternal zinc, iron, folic acid, and protein nutriture and outcome of human pregnancy. Am J Clin Nutr. 1984; 40:496-507.
35. Lazebnik N, Kuhnert BR, Kuhnert PM. Zinc, cadmium, and hypertension in parturient women. Am J Obstet Gynecol. 1989;161:437-440.
36. Higashi A, Tajiri A, Matsukura M, Matsuda I. A prospective survey of serial maternal serum zinc levels and pregnancy outcome. J Pediatr Gastroenterol Nutr. 1988;7:430-433.
37. Soltan MH, Jenkins DM. Maternal and fetal plasma zinc concentration and fetal abnormality. Br J Obstet Gynaecol. 1982;89:56-58.
38. Ghishan FK, Said HM, Wilson PC, Murrell JE, Green HL. Intestinal transport of zinc and folic acid: a mutual inhibitory effect. Am J Clin Nutr. 1986;43:258-262.
39. Fuller NJ, Bates CJ, Lucas A. High folate intakes related to zinc status in preterm infants. Eur J Pediatr. 1992;151:51-53.
40. Milne DB. Effects of folic acid supplements on zinc-65 absorption and retention. J Trace Elem Exp Med. 1989;2:297-304.
41. Zimmermann MB, Shane B. Supplemental folic acid. Am J Clin Nutr. 1993;58:127-128.
42. Kauwell GP, Bailey LB, Gregory JF III, Bowling DW, Cousins RJ. Zinc status is not adversely affected by folic acid supplementation and zinc intake does not impair folate utilization in human subjects. J Nutr. 1995;125:66-72.
43. Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr. 1989; 50:353-358.
44. 12. In: Shils ME, Young VR, eds. Modern Nutrition in Health and Disease. 7th ed. Philadelphia, Pa: Lea & Febiger; 1988:388-413.
45. Yetley E. Folate. Washington, DC: Federation for American Societies of Experimental Biology; 1996.
46. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr. 1989;50:508-516.